Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BOPA 2017 | The potential for patient-level data in the NHS

Bryn Thomas • 6 Oct 2017
BOPA 2017
General

In today’s digitally advanced society, large volumes of patient-level data can be collected and compiled. With an ever-increasing demand upon healthcare resources, this could have numerous benefits. Speaking from the British Oncology Pharmacy Association (BOPA) 20th Annual Symposium 2017 in Glasgow, UK, Bryn Thomas of The Royal Marsden NHS Foundation Trust, London, UK discusses the advantages of the use of patient-level data in the NHS and the challenges in this area moving forwards, which include technical aspects, quality control and public perception.

More from Bryn Thomas

3:33
The developing role of pharmacist prescribers
Bryn Thomas • 6 Oct 2016
1:47
Driving efficiency improvements in the NHS
Bryn Thomas • 6 Oct 2017

Related Videos

4:07
Pooled fecal allogeneic microbiotherapy to treat refractory gastrointestinal acute GvHD
Florent Malard • 11 Apr 2024
5:23
Current and emerging treatment approaches for steroid-refractory acute & chronic GvHD
Mohamad Mohty • 17 Apr 2024
2:00
HHV-6 reactivation after haploidentical transplantation with PTCy & ATG: incidence and risk factors
Rémy Duléry • 15 Apr 2024
1:41
The consequences of regulatory changes on access to devices and reagents needed for graft processing
Christian Chabannon • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals